Narashino, Japan

Hidefumi Ohsawa

This inventor holds 1 USPTO granted patent. Top assignee: Tokyo Tanabe Company, Ltd.. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hidefumi Ohsawa. Retrieved from https://idiyas.com/inventor/hidefumi-ohsawa-djwout5m

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Hidefumi Ohsawa

Introduction

Hidefumi Ohsawa is a notable inventor based in Narasino, Japan. He has made significant contributions to the field of medical technology, particularly in the area of arteriosclerosis treatment. His work has been recognized for its potential impact on health and wellness.

Latest Patents

Ohsawa holds a patent for an arteriosclerosis depressant. This innovation aims to provide a new approach to managing and treating arteriosclerosis, a condition that affects many individuals worldwide. His patent is a testament to his dedication to improving healthcare solutions.

Career Highlights

Ohsawa is currently associated with Tokyo Tanabe Company, Ltd. His role in the company has allowed him to focus on research and development, contributing to advancements in medical technology. His expertise and innovative mindset have positioned him as a valuable asset in his field.

Collaborations

Throughout his career, Ohsawa has collaborated with esteemed colleagues such as Masao Moroi and Toshio Kawashima. These partnerships have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking solutions.

Conclusion

Hidefumi Ohsawa's contributions to the field of medical technology, particularly through his patent for an arteriosclerosis depressant, highlight his commitment to innovation and healthcare improvement. His work continues to inspire advancements in medical treatments and technologies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…